AVIR
Atea Pharmaceuticals Inc.
$3.25
-$0.02(-0.61%)
62
Overall
60
Value
81
Tech
47
Quality
Market Cap
$254.74M
Volume
660.48K
52W Range
$2.46 - $4.02
Target Price
$6.00
EPS Estimates Overview
| Current Quarter | $-0.46 | Next Quarter | $-0.48 |
| Current Year | $-1.79 | Next Year | $-1.79 |
| QoQ Growth | -4.3% | YoY Growth | +0.0% |
| 3Y EPS CAGR | -49.9% | Target Price | $6.00 |
| Consensus | Buy | Upside | +84.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVIR | $3.25 | -0.6% | 660.48K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Atea Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW